Cargando…
Change and clinical significance of serum cortisol, BNP, and PGE-2 levels in premature infants with patent ductus arteriosus
BACKGROUND: To analyze the change and clinical significance of cortisol, B-type brain natriuretic peptide (BNP), and prostacyclin-2 (PGE-2) levels in premature infants with patent ductus arteriosus (PDA). METHODS: A total of 67 cases of premature infants admitted to our hospital from January 2018 to...
Autores principales: | Cui, Qintao, Liu, Xiaochen, Su, Guobao, Zhou, Chaoyuan, Wang, Junhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578766/ https://www.ncbi.nlm.nih.gov/pubmed/34765481 http://dx.doi.org/10.21037/tp-21-450 |
Ejemplares similares
-
Exploring the NT-proBNP expression in Premature Infants with Patent Ductus Arteriosus (PDA) by Echocardiography
por: Shi, Yunlong, et al.
Publicado: (2021) -
Management of Patent Ductus Arteriosus in Premature Infants in 2020
por: Parkerson, Sarah, et al.
Publicado: (2021) -
Antenatal Magnesium Sulfate Exposure and Hemodynamically Significant Patent Ductus Arteriosus in Premature Infants
por: Qasim, Amna, et al.
Publicado: (2019) -
B-type natriuretic peptide for assessment of haemodynamically significant patent ductus arteriosus in premature infants
por: Mine, Kenji, et al.
Publicado: (2013) -
Predictors of Bronchopulmonary Dysplasia or Death in Premature Infants with a Patent Ductus Arteriosus
por: Chock, Valerie Y., et al.
Publicado: (2013)